Papp, Z, Agostoni, P, Alvarez, J, Bettex, D, Bouchez, S, Brito, D
, Černý, V, Comin-Colet, J, Crespo-Leiro, MG, Delgado, JF, Édes, I, Eremenko, AA, Farmakis, D, Fedele, F, Fonseca, C, Fruhwald, S, Girardis, M, Guarracino, F, Harjola, VP, Heringlake, M, Herpain, A, Heunks, LMA, Husebye, T, Ivancan, V, Karason, K, Kaul, S, Kivikko, M, Kubica, J, Masip, J, Matskeplishvili, S, Mebazaa, A, Nieminen, MS, Oliva, F, Papp, JG, Parissis, J, Parkhomenko, A, Põder, P, Pölzl, G, Reinecke, A, Ricksten, SE, Riha, H, Rudiger, A, Sarapohja, T, Schwinger, RHG, Toller, W, Tritapepe, L, Tschöpe, C, Wikström, G, Lewinski, DV, Vrtovec, B & Pollesello, P 2020, '
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use',
Journal of Cardiovascular Pharmacology, vol. 76, no. 1, pp. 4-22.
https://doi.org/10.1097/FJC.0000000000000859